L-Glutamine Conclusion / References
by Ivy Greenwell -- reprinted by permission from Bill Faloon of
The Life Extension Foundation
Glutamine, the most abundant
amino acid in humans, is vital to the proper functioning of our bodies.
While the role of glutamine in these
and other situations is promising, additional research is needed.
The role of glutamine in the body
and the potential advantages of glutamine
supplementation for individuals is the focus of on-going intense
research efforts throughout the world.
There is also a suspicion that toxic residues from
the compounds formerly used for bleaching white flour may have contributed to the increase
in neurodegenerative diseases -- again by inhibiting glutamine synthase. A big challenge in
neuro-protection is avoiding neurotoxins that might impair
the quick conversion of glutamate to glutamine thus, enhancing the production of
(of vitamins/minerals, etc. -- not
fasting) can likewise lead to glial
and thus to the inability of glia to remove excitatory neurotransmitters (glutamate and
aspartate) from the synaptic junctions. In summary, glutamate excitotoxicity arises only
under certain pathological conditions such as stroke, extremely high fever, certain viral
infections, the presence of neurotoxins, or severe inflammation.
It can be due
to excess release of glutamate by the neurons (stroke)
and/or to glial malfunction where the glia
are incapable of secreting enough glutamine synthase in order to convert glutamate to
glutamine. Glutamine as such cannot harm the brain. On the contrary, it is very beneficial
to the brain. Any excess glutamine simply leaves the brain, being donated to the body.
There are many reasons for taking
l-glutamine: Healthier intestines, stronger immune system, enhanced
muscle tone, helps combat fatigue and blood sugar issues and encourages a more agile brain. For therapeutic uses, glutamine is especially recommended for
people who suffer from problems such as Irritable Bowel Syndrome, colitis, Chron's Disease, frequent NSAID users who need to protect their
gastrointestinal tract, and anyone under heavy stress
(including strenuous exercise) or recovering from injury or other trauma.
It may also be
helpful as an adjunct therapy for decreasing alcohol use and/or cocaine and
its derivatives. It supports growth
release (when taken on an empty stomach before exercise or bedtime). It is also used by athletes to improve exercise
endurance since it can actually turn itself into a carbohydrate when carbohydrate depleted.
and d,l phenylalanine in association
with L-Glutamine is an additional consideration concerning lessening the desire
for alcohol and carbohydrates.
Glutamine has a long history of curbing the desire for alcohol and
Take 5-20 grams of L-Glutamine per day when needed, between 2 and 3 grams at the
onset of a desire for sweets and/or alcohol, and up to 40 grams per day for more
Even though glutamine is nontoxic, it
is recommended that you consult a health practitioner before using high doses.
canc patients, patients with advanced liver disease, and those with neurological
diseases including stroke and epilepsy should use glutamine only with the permission of
1. Hendler, Sheldon S.,
Ph.D., M.D., & Rorvik, David, M.S. (Editors). PDR for Nutritional
Supplements. New Jersey: Medical Economics Company, 2001:189-91.
2. Reinaldo A., et al. Branched-chain amino acid supplementation and
long-distance athletes. Nutrition 2002 May;18(5):376-9.
3. Talbott, Shawn M., Ph.D. A Guide to Understanding Dietary
Supplements. New York: The Haworth Press, 2003:414-5.
4. Miller A. Considerations of l-glutamine: A review of the literature.
Altern Med Rev 1999 Aug;4(4):239-48.
5. Vante JP et al. Plasma-amino acid profiles in sepsis and stress. Ann
Surg 1989 Jan;209(1):57-62.
6. Krebs H. Glutamine metabolism in the animal body. In: Mora J,
Palacios R (Editors). Glutamine: metabolism enzymology and regulation.
Academic Press, 1980:319-29.
7. Atkins, Robert C., M.D. Dr. Atkin's Vita-Nutrient Solution. New York:
Simon & Schuster, 1998:167-170.
8. Neu J, et al. Glutamine: clinical applications and mechanisms of
action. Curr Opin Clin Nutr Metab Care 2002 Jan;5(1):69-75.
10. Ardawi MSM, et al. Glutamine metabolism in rats. Biochem J 1983 Jun
11. Ardawi MSM, et al. Glutamine and its importance.
Essays Biochem 1985;21:1-44.
12. Ziegler TR. Glutamine supplementation. Br J Nutr 2002 Jan;87(suppl
13. Andrews FJ, et al. Glutamine: essential for nutrition. Br J Nutr
2002 Jan;87 (suppl 1):S3-8.
16. Castell LM, et al. Does glutamine have a role in athletes? Eur J
Appl Physiol Occup Physiol 1996;73(5):488-90.
17. Nieman D, et al. Exercise and glutamine function. Recent
developments. Sports Med 1999 Feb;27(2):73-80.
18. Rohde T, et al. Effect of glutamine supplementation in repeated
exercise. Med Sci Sports Exerc 1998 Jun;30(6):856-62.
19. Rennie MJ, et al. Amino acid transport during muscle contraction and
exercise. Adv Exp Med Biol 1998;441:299-305.
20. Antonio J, Ph.D., & Stout J., Ph.D. (Editors). Sports Supplement
Encyclopedia Edition 1. Colorado: Nutricia Institute of Sports Science,
21. Hankard RG, et al. Effect of glutamine on leucine metabolism in
humans. Am J Physiol 1996 Oct ;271 (4 Pt 1): E748-54.
Baas D et al. Glutamine synthase expression and
activity are regulated by triodo-L-thyronine and hydrocortisone in rat oligodendrocyte
cultures. Int J Dev Neurosci 1998;16:333-40.
23. Bartlett DL et al. Effect of glutamine on tumor and
host growth. Ann Surg Oncol 1995;2:71-6.
24. Curthoys N et al. Regulation of glutaminase activity
and glutamine metabolism. Annu Rev Nutr 1995; 15:133-59.
25. Dall'Asta V et al. Amino acids are compatible
osmolytes for volume recovery after hypertonic shrinkage in vascular endothelial cells.
J Physiol 1996; 276:C865-72.
26. Furukawa S et al. Glutamine-enhanced bacterial
killing by neutrophils from postoperative patients. Nutrition 1997; 13:863-9.
27. Firshein R.
The Neutraceutical Revolution.
Riverhead Books, 1998.
28. Fraser CM et al. Effects of anti-epileptic drugs on
glutamine synthase activity in the mouse brain. Br J Pharmacol 1999; 126:1634-8.
29. Hickson RC et al. Protective effect of glutamine
from glucocorticoid-induced muscle atrophy occurs without alterations in circulating
insulin-like growth factor and IGF-binding protein levels. Proc Soc Exp Biol Med
30. Hond ED et al. Effect of glutamine on the intestinal
permeability changes induced by indomethacin in humans. Aliment Pharmacol Ther
31. Huang TL, O'Banion MK. Interleukin-1 beta and tumor
necrosis factor alpha suppress dexamethasone induction of glutamine synthetase in primary
mouse astrocytes. J Neurochem 1998; 71:1436-42.
32. Kash San Francisco et al. Increased anxiety and
altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid
decarboxylase. Proc National Acad Sci USA 1999; 96:1698-703.
33. Klimberg VS et al. Glutamine suppresses PGE2
synthesis and breast canc growth. J Surg Res 1996; 63:293-7.
34. Khogali SE et al. Effects of l-glutamine on post-ischaemic cardiac function: protection and rescue.
J Mol Cell Cardiol 1998;
35. Kort JJ. Impairment of excitatory amino acid
transport in astroglial cells infected with the human immunodeficiency virus type 1.
Res Hum Retroviruses 1998; 14:1329-39.
36. Kumar D et al. Biochemical and immunological changes
on oral glutamate feeding in male albino rats. Int J Biometeorol 1999;42:201-4.
37. Lavoinee A et al. Glutamine and regulation of gene
expression in rat hepatocytes. Biochimie 1998; 80:807-11.
38. Lieth E et al. Glial reactivity and impaired
glutamine metabolism in short-term experimental diabetic retinopathy. Diabetes
39. MacBurney M et al. A cost-evaluation of glutamine-supplemented parenteral nutrition in
adult bone marrow transplant patients. J Am Diet Assoc 1994; 94:1263-6.
40. Morimoto T et al. Pathogenic role of glutamate in hyperthermia-induced seizures.
Epilepsia 1993; 34:447-52.
41. Niihara Y et al. Oral l-glutamine therapy for sickle
cell anemia: subjective clinical improvement and favorable changes in red cell redox
potential. Am J Hematol 1998; 58:117-21.
42. Nordmann R, Rouach H. Alcohol and free radicals:
from basic research to clinical prospects. Bull Acad National Med 1995;
43. O'Byrne M et al. Assessment of neurotoxicity and
neuro protection. J Neural Transm Suppl 1997;50:153-64. Packer L and Colman C.
The Antioxidant Miracle. John Wiley & Sons, 1999, p.130.
44. Petroff OA et al. Initial observations on effect of
vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate,
and glutamine in human brain. Epilepsia 1995;36:457-64.
45. Pieterson HG. Glutamate metabolism of the heart
during coronary artery bypass. Clin Nutr 1998; 17:73-5.
46. Rubio IT et al. Effect of glutamine on methotrexate
efficacy and toxicity. Ann Surg 1998; 227:772-8.
47. Sacks GS. Glutamine supplementation in catabolic
patients. Ann Pharmacother 1999; 33:348-54.
48. Sears B. The Anti-Aging Zone. Regan Books,
1999, pp 108-109.
49. Shaw CA, Bains JS. Did consumption of flour bleached
by the agene process contribute to the incidence of neurological disease? Med
Hypotheses 1998; 51:477-81.
50. Stumvoll M et al. Role of glutamine in human
carbohydrate metabolism in kidney and other tissue. Kidney Int 1999; 55:778-92.
51. Tsacopoulos M et al. The nutritive function of glia
is regulated by signals released by neurons. Glia 1997; 21: 84-91.
52. Walsh NP et al. Glutamine, exercise and immune
function. Links and possible mechanisms. Sports Med 1998; 26:177-91.
53. Wilmore DW. Postoperative protein sparing.
J Surgery 1999;23:545-52.
54. Wu G. Intestinal mucosal amino acid catabolism.
55. Zhu L et al. Antagonistic effects of extract from
leaves of ginkgo biloba on glutamate neurotoxicity. Chung Kuo Yao Li Hsueh Pao
(abstract in English). 1997:18:344-7.
56. Zipp F et al. L-Glutamine synthase activity in
patients with Parkinson's disease. Acta Neurol Scand 1998; 97:300-2.
2 | Pg
3 | Pg
4 | Pg